AISAP Cardio vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

AISAP Cardio is an AI-powered software platform designed for rapid, comprehensive cardiac diagnostic assessments and measurements using point-of-care ultrasound, focusing on structural heart disease and heart failure. In contrast, the Verily Study Watch is a prescription-only wearable device that collects physiological data, including ECG and irregular pulse monitoring, primarily for atrial fibrillation detection and clinical research. While both leverage AI in cardiology and are FDA-cleared, AISAP Cardio serves as a diagnostic aid for clinicians interpreting imaging, whereas the Study Watch functions as a remote monitoring tool for patients.

Choose AISAP Cardio if…

Choose AISAP Cardio if you require rapid, AI-powered, comprehensive cardiac diagnostic assessments and measurements directly at the point of care. This tool is ideal for clinicians needing immediate, detailed insights into structural heart disease, heart failure, and valvular pathologies, with automated report generation for seamless integration into existing clinical workflows.

View AISAP Cardio →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if your focus is on unobtrusive, long-term physiological data collection and continuous irregular pulse monitoring for conditions like AFib, especially within clinical research or remote patient management programs. This prescription-only wearable is designed for extended data gathering, providing insights into trends and events over time rather than a single point-in-time assessment.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio Study Watch with Irregular Pulse Monitor (Home)
Deployment Cloud-based Unknown
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio is designed to streamline clinical workflows at the point of care, offering rapid, AI-powered interpretation and automated reporting integrated with existing EHR/EMR and PACS systems. This directly enhances usability for healthcare professionals by providing immediate diagnostic insights within their established environment. In contrast, the Verily Study Watch, while user-friendly for patients, focuses on remote data collection, which may require additional steps for clinicians to access and interpret.

Clinical Value

AISAP Cardio

AISAP Cardio provides comprehensive cardiac diagnostic assessments and measurements for a wide range of conditions, including structural heart disease, heart failure, and valvular pathologies, offering immediate and broad clinical insights at the point of care. The Verily Study Watch, while valuable and FDA-cleared, is more focused on continuous monitoring and early detection of atrial fibrillation. AISAP Cardio's broader diagnostic scope for critical conditions gives it an edge in immediate clinical value.

Pricing & Value

Tie

Neither AISAP Cardio nor the Verily Study Watch provides publicly available pricing information. Both require direct contact for demos and pricing details, making it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

AISAP Cardio

AISAP Cardio is a cloud-based SaaS platform that is explicitly described as vendor-agnostic, scalable, and designed for integration with existing clinical workflows, EHR/EMR, and PACS. These features are crucial for seamless enterprise adoption and deployment within diverse healthcare IT environments. While Verily Study Watch has a confirmed Business Associate Agreement (BAA) and on-device data encryption, AISAP Cardio's explicit focus on broad system integration provides a stronger foundation for enterprise readiness.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. AISAP Cardio innovates by bringing AI-powered interpretation for comprehensive cardiac point-of-care ultrasound, democratizing advanced diagnostics and automating reporting. The Verily Study Watch is innovative as a prescription-only, multi-sensor wearable for unobtrusive, continuous physiological data collection and irregular pulse monitoring, pushing the boundaries of remote patient monitoring.

Support & Docs

Study Watch with Irregular Pulse Monitor (Home)

Verily provides more explicit details regarding its support and documentation, including 'Data Workbench resources' with forums, tutorials, and product documentation, as well as downloadable regulatory information PDFs for the Study Watch itself. A user manual for the Verily Study Watch is also publicly available. AISAP Cardio offers various email contacts and a phone number for support, but less explicit detail on comprehensive documentation or user forums.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio Study Watch with Irregular Pulse Monitor (Home)
Name AISAP Cardio Study Watch with Irregular Pulse Monitor (Home)
Description FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. Prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Company Aisap Verily Life Sciences LLC
Primary Functionality AI-powered interpretation for early cardiac disease detection; comprehensive cardiac ultrasound software package; automated generation of analyses, interpretations, and reports. On-demand single-channel ECG measurement; irregular pulse monitoring for atrial fibrillation (AFib) detection; collection of multiple physiological and environmental sensors.
Key Measurements/Assessments Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); Measurement of Left Ventricle Ejection Fraction (LVEF); Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Heart rate, electrodermal activity, inertial movements; Environmental sensors; Long battery life (up to one week); Large internal data storage with compression; On-device data encryption for security.

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform designed for rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, enabling early detection of structural heart disease and heart failure. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, focused on unobtrusively collecting physiological data, including on-demand ECG and irregular pulse monitoring for AFib detection.
AISAP Cardio acquires data through its AI-powered software platform that interprets point-of-care ultrasound images, providing automated analyses, interpretations, and reports. In contrast, the Verily Study Watch is a wearable device that collects physiological data via advanced sensors, including on-demand single-channel ECG measurements and continuous irregular pulse monitoring.
AISAP Cardio is designed for the early detection of structural heart disease and heart failure, including assessments of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), and measurements of Left Ventricle Ejection Fraction (LVEF), ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. The Verily Study Watch focuses on irregular pulse monitoring for atrial fibrillation (AFib) detection and provides on-demand single-channel ECG measurements.
AISAP Cardio provides comprehensive cardiac diagnostic assessments, including measurements of Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter, along with interpretations of valvular pathologies. The Verily Study Watch offers on-demand single-channel ECG measurements and monitors for irregular pulses, primarily for AFib detection.
AISAP Cardio is an AI-powered point-of-care ultrasound software platform intended for use by clinicians in specialties like Cardiology, Emergency Medicine, and Radiology at the bedside. The Verily Study Watch is a prescription-only wearable device designed for patient home use, primarily for clinical research and remote healthcare monitoring.

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor (Home)

AI Tool Finder
AI-powered search. Results may not be comprehensive.